Study guide
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi
UEMS European Board of Dermatovenereology Diploma Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Eligibility & Examination Regulations
1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition
2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology
2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns
3 Chapter 3: Dermatopathology & Diagnostic Procedures
3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy
4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology
4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance
5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease
5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders
6 Chapter 6: Hair, Nails & Pigmentary Disorders
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation
7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease
7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses
8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease
8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease
9 Chapter 9: Autoimmune Bullous Diseases
9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis
10 Chapter 10: Eczematous Disorders, Urticaria & Allergology
10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy
11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis
11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses
12 Chapter 12: Paediatric & Genetic Dermatology
12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa
13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections
13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
14 Chapter 14: Viral & Fungal Cutaneous Infections
14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses
15 Chapter 15: Sexually Transmitted Infections & Genital Infections
15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis
16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine
16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems
17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours
17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases
18 Chapter 18: Melanocytic Naevi & Melanoma
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma
19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas
19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas
20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing
20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy
21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy
22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision
22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi
Key Takeaways Explain This Topic AI
Congenital melanocytic naevi are classed by projected adult size as small (under 1.5 cm), medium (1.5 to 20 cm), large (20 to 40 cm), and giant (over 40 cm), and melanoma risk is concentrated in large and giant naevi.
Infants with a large or giant congenital naevus with many satellite lesions, or with multiple medium naevi, should be offered brain and spine MRI to look for neurocutaneous melanosis.
Spitz naevi are typically pink or pigmented dome-shaped papules in children, and dermoscopy often shows a starburst pattern or regular dotted vessels.
BAP1-inactivated melanocytic tumours are skin-coloured dome-shaped papules and can signal the BAP1 tumour predisposition syndrome, with risks of uveal melanoma, mesothelioma, and renal cancer.
Having more than about 50 common naevi or several clinically atypical naevi is one of the strongest phenotypic risk factors for cutaneous melanoma.
Last updated: September 2026
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi
A melanocytic naevus is a benign proliferation of melanocytes in nests. Knowing the normal variants is essential for Session 4 (Dermato-Oncology and Dermoscopy). Melanoma itself is covered in the melanoma chapter.
Acquired Common Naevi
Common naevi appear from early childhood, increase in number until about the third or fourth decade, and then slowly regress. Many start as junctional naevi (nests at the dermo-epidermal junction; flat, evenly brown), become compound (junctional and dermal nests; slightly raised), and finally intradermal (dermal nests only; skin-coloured, dome-shaped, often on the face).
Driver mutations: BRAF V600E in most acquired naevi, which then enter a stable growth arrest (oncogene-induced senescence).
Risk marker: having more than about 50 common naevi , or several clinically atypical naevi, is one of the strongest phenotypic risk factors for melanoma.
Common benign dermoscopic patterns: reticular (network), globular (common in children and on the trunk of young people), homogeneous , and mixed patterns such as reticular centre with peripheral globules. A symmetric rim of peripheral globules is normal in a growing naevus in a child or adolescent, but in older adults it needs monitoring. A patient's naevi tend to look alike (the "signature" naevus); a lesion that differs is the "ugly duckling" .
Congenital Melanocytic Naevi (CMN)
CMN are present at birth or appear in the first months. They often show hypertrichosis and texture change. Most are driven by NRAS mutations.
- Category (projected adult size) Size
- Small Under 1.5 cm
- Medium 1.5–20 cm
- Large 20–40 cm
- Giant Over 40 cm
Melanoma risk is concentrated in large and giant CMN , especially with many satellite naevi . Melanoma may arise deep in the naevus or in the central nervous system, often in childhood. The risk from small and medium CMN is low.
Neurocutaneous melanosis: melanocytic proliferation in the leptomeninges, which can cause hydrocephalus, seizures, and CNS melanoma. Offer MRI of the brain and spine (ideally in the first months of life) to infants with large or giant CMN with multiple satellites, or with multiple medium CMN .
Proliferative nodules within CMN in infancy are usually benign but may need biopsy.
Management is individual. Prophylactic removal of a large CMN has not been proven to reduce melanoma risk. The aims are regular examination with photographs, prompt biopsy of new nodules, and help with appearance and psychosocial impact.
Spitz and Reed Naevi
Lesion Clinical Dermoscopy Histology and Genetics
Spitz naevus Pink, red, or tan dome-shaped papule, usually in children and adolescents , often on the face or legs; grows quickly and then stabilises Regular dotted vessels (pink types); starburst pattern (pigmented types) Large epithelioid and/or spindle melanocytes, Kamino bodies . Drivers include HRAS mutations and kinase fusions ( ALK , ROS1 , NTRK , BRAF )
Reed naevus (pigmented spindle cell naevus) Dark brown-black flat papule, often on the thighs of young women Starburst pattern Heavily pigmented spindle melanocytes
Atypical Spitz tumour Larger, asymmetric, or ulcerated Irregular Intermediate features; specialist review and complete excision
In children with a typical symmetric Spitz or Reed pattern, many European experts accept dermoscopic monitoring rather than immediate excision. In adults , and for any atypical or changing lesion, excision is advised because spitzoid melanoma is a mimic.
Blue Naevi
Dermal proliferation of pigmented dendritic melanocytes , often with GNAQ or GNA11 mutations.
Clinically blue-grey because deep pigment scatters short (blue) wavelengths (the Tyndall effect ).
Dermoscopy shows homogeneous structureless blue pigment .
Cellular blue naevi are larger nodules, often on the buttocks or scalp. A new or changing blue lesion in an adult needs excision, because melanoma metastases and nodular melanoma can look similar.
Other Naevus Variants
Variant Key Points
Halo (Sutton) naevus A naevus with a white halo from immune destruction, common in adolescents; linked to vitiligo. In an adult, examine the whole skin for melanoma, which can trigger halo reactions
Recurrent naevus ("pseudomelanoma") Pigment regrowth in a scar after incomplete removal; can mimic melanoma on histology, so give the pathologist the previous report
Naevus spilus (speckled lentiginous naevus) A light-brown patch with darker speckles; a small melanoma risk in large lesions
Special-site naevi Genital, breast, ear, flexural, and scalp naevi can show atypical histology while behaving benignly
Acral naevi Dermoscopy shows the parallel furrow , lattice-like, or fibrillar patterns; the parallel ridge pattern suggests acral melanoma
Meyerson naevus A naevus with an eczematous halo
Combined and deep penetrating naevi Mixed populations, including blue-naevus-like components; some carry beta-catenin activation and need expert review
Naevi in pregnancy May darken or enlarge slightly; changing lesions are assessed on the same criteria as at any other time
Atypical (Dysplastic) Naevi
Clinically atypical naevi: usually 5 mm or larger , with irregular or blurred borders, variegated colour, and a flat component. Many are benign. They mark a raised melanoma risk, particularly in familial atypical multiple mole melanoma (FAMMM) syndrome, often due to CDKN2A mutations.
Histology: architectural disorder and cytological atypia. The WHO classification grades dysplastic naevi as low-grade or high-grade .
Margins: low-grade (mild or moderate) dysplastic naevi with positive margins usually do not need re-excision if the lesion was completely sampled. High-grade (severe) dysplastic naevi are generally re-excised with a small clear margin (several millimetres).
Removing all atypical naevi prophylactically is not recommended.
BAP1-Inactivated Melanocytic Tumours
These are skin-coloured to pink dome-shaped papules , often multiple, with large epithelioid melanocytes showing loss of BAP1 staining . Germline BAP1 mutations cause the BAP1 tumour predisposition syndrome , with raised risks of uveal melanoma, mesothelioma, renal cell carcinoma , cutaneous melanoma, and basal cell carcinoma. Several such lesions, or a family history of these cancers, should prompt genetic referral.
Practical Management of Naevi
Total body skin examination with dermoscopy for anyone with many or atypical naevi, a personal or family history of melanoma, or a changing lesion. Imaging tools for surveillance are covered in the non-invasive imaging section.
Excise a lesion with melanoma-specific dermoscopic features, a lesion that has changed on sequential imaging, an "ugly duckling", or a new pigmented lesion in an older adult. For flat lesions without melanoma features, a short-term (about 3-month) digital dermoscopy review can detect change.
Excise suspicious lesions completely (a 1–3 mm margin), orient the specimen, and give the pathologist a clinical description.
Teach self-examination and sun protection.